X-Linked Inhibitor of Apoptosis Protein as a Therapeutic Target in Metastatic Melanoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1038/jid.2010.205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Melanoma Inhibitor of Apoptosis Protein (ML-IAP) Is a Target for Immune-Mediated Tumor Destruction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2008English

A Novel Mutation in the X-Linked Inhibitor of Apoptosis Protein Causing a Multi-System Autoinflammatory Disorder

Annals of Paediatric Rheumatology
2012English

Role of X-Linked Inhibitor of Apoptosis in Breast Cancer

2008English

Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2020English

X-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibits Caspase-3 and -7 in Distinct Modes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Overexpression of X-Linked Inhibitor of Apoptosis Protein Protects Against Noise-Induced Hearing Loss in Mice

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

X-Linked FHL1 as a Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy